• Return to Headlines

Clovis Oncology Shares Down 77.0% Since SmarTrend's Sell Call (CLVS)

By David Diaz

SmarTrend identified a Downtrend for Clovis Oncology (NASDAQ:CLVS) on March 25th, 2019 at $23.84. In approximately 5 months, Clovis Oncology has returned 76.97% as of today's recent price of $5.49.

Over the past year, Clovis Oncology has traded in a range of $5.20 to $37.27 and is now at $5.49, 6% above that low. The 200-day and 50-day moving averages have moved 1.1% lower and 4.33% lower over the past week, respectively.

Clovis Oncology Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing, and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. Clovis target its development programs for the treatment of specific subsets of cancer populations.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Clovis Oncology.

Log in and add Clovis Oncology (CLVS) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights clovis oncology

Ticker(s): CLVS